MMX
Live / Registered — Registered (as of 14 Sept 2021)
What this means for you
Registered since 14 Sept 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88820915
- Registration number
- 6481563
- Mark type
- Stylized text
- Filed
- 04 Mar 2020
- Published for opposition
- 29 Jun 2021
- Registered
- 14 Sept 2021
- Attorney of record
- John Pickerill
Goods and services
- Class 005 — Pharmaceuticals: Contrast media for use with medical equipment or in medical imaging, namely, endoscopy, x-ray, ultrasound, MRI, PET and CT equipment; Diagnostic agents and reagents for medical use; Diagnostic preparations for medical purposes; Pharmaceutical preparations and substances, namely, prescription medicines in the form of pills, tablets, capsules, caplets, and liquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders, gastrointestinal diseases or digestive system disorders; Pharmaceutical preparations for the treatment or prevention of IBS (irritable bowel syndrome); Non-prescription medicines, namely, pills, tablets, capsules, caplets, and liquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with gastroscopic, endoscopic, colonoscopic, sigmoidoscopic, anoscopic, rectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detection, diagnosis, prevention or treatment of gastroenterological diseases; pharmaceutical preparations for use in gastroenterology, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceutical, medical and surgical purposes, namely, detection, diagnosis, prevention or treatment of gastroenterological diseases; Medical and surgical dyes, namely, methylene blue dye; Medical dyes for pharmaceutical and diagnostic purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations for the diagnosis, prevention or treatment of ulcerative colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertility, reproductive health, hematology, urology, gynecology, obstetrics, endocrinology, oncology, renalology, immunology and inflammatory diseases, disorders and conditions; pharmaceutical preparations for colon and digestive system health and regulation, for improving energy levels or for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; Anti-nausea medication; antiemetic preparations; antibiotic preparations; pharmaceutical preparations for the treatment or prevention of travelers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis
- Class 044 — Medical, beauty and agricultural services: Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Owner
- Cosmo Technologies Ltd, Rochester, NY, IE
- Cosmo Technologies Ltd, Rochester, NY, IE
- Cosmo Technologies Ltd, Rochester, NY, IE
Prosecution history
- 14 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 29 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jun 2021 — PUBLISHED FOR OPPOSITION
- 09 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 May 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 May 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 May 2021 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 19 Mar 2021 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 19 Mar 2021 — LETTER OF SUSPENSION E-MAILED
- 19 Mar 2021 — SUSPENSION LETTER WRITTEN
- 12 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Mar 2021 — ASSIGNED TO LIE
- 08 Dec 2020 — NOTICE OF REVIVAL - E-MAILED